Critical role of plectin in anti-migration potential of curcumin

Food Science and Biotechnology

Volumn 20, Issue 6, 2011, Pages 1615-1624

  Ha, Young Ran ^a   Choi, Yong Wook ^a   Lee, Sang Joon ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

anti oxidant; curcumin; plectin; tumor invasion; tumor migration

Indexed keywords

ANTI-OXIDANTS; CANCER CELL LINES; CANCER CELLS; CELL MIGRATION; CURCUMIN; CYTOSKELETONS; DOWN-REGULATION; EPITHELIAL CELLS; GENISTEIN; HUMAN BREAST; LINKER PROTEINS; LUNG CANCER CELLS; PLECTIN; SIGNALING PATHWAYS; TUMOR INVASION; WOUND HEALING;

CELL CULTURE; DISEASES; TUMORS;

CELLS;

EID: 84862937418     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10068-011-0223-2     Document Type: Article

References (44)

1. Na S, Chowdhury F, Tay B, Ouyang M, Gregor M, Wang Y, Wiche G, Wang N. Plectin contributes to mechanical properties of living cells. Am. J. Physiol.-Cell Ph. 296: C868-C877 (2009).
2. Andra K, Nikolic B, Stocher M, Drenckhahn D, Wiche G. Not just scaffolding: Plectin regulates actin dynamics in cultured cells. Gene. Dev. 12: 3442-3451 (1998).
3. Ding Y, Zhang L, Goodwin JS, Wang Z, Liu B, Zhang J, Fan GH. Plectin regulates the signaling and trafficking of the HIV-1 coreceptor CXCR4 and plays a role in HIV-1 infection. Exp. Cell Res. 314: 590-602 (2008).
4. Svitkina TM, Verkhovsky AB, Borisy GG. Plectin sidearms mediate interaction of intermediate filaments with microtubules and other components of the cytoskeleton. J. Cell Biol. 135: 991-1007 (1996).
5. Wiche G. Role of plectin in cytoskeleton organization and dynamics. J. Cell Sci. 111: 2477-2486 (1998).
6. Lee KY, Liu YH, Ho CC, Pei RJ, Yeh KT, Cheng CC, Lai YS. An early evaluation of malignant tendency with plectin expression in human colorectal adenoma and adenocarcinoma. J. Med. 35: 141-149 (2004).
7. Stegh AH, Herrmann H, Lampel S, Weisenberger D, Andrä K, Seper M, Wiche G, Krammer PH, Peter ME. Identification of the cytolinker plectin as a major early in vivo substrate for caspase 8 during CD95-and tumor necrosis factor receptor-mediated apoptosis. Mol. Cell Biol. 20: 5665-5679 (2000).
8. Sonnenberg A, Liem RK. Plakins in development and disease. Exp. Cell Res. 313: 2189-2203 (2007).
9. Bausch D, Thomas S, Mino-Kenudson M, Fernández-del CC, Bauer TW, Williams M, Warshaw AL, Thayer SP, Kelly KA. Plectin-1 as a novel biomarker for pancreatic cancer. Clin. Cancer Res. 17: 302-309 (2011).
10. Vazeille E, Slimani L, Claustre A, Magne H, Labas R, Béchet D, Taillandier D, Dardevet D, Astruc T, Attaix D, Combaret L. Curcumin treatment prevents increased proteasome and apoptosome activities in rat skeletal muscle during reloading and improves subsequent recovery. J. Nutr. Biochem. 22: in press (2011).
11. Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL, Lin JP, Ma YS, Wu CC, Chung JG. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor (VEGF). Cancer Lett. 285: 127-133 (2009).
12. Wang L, Shen Y, Song R, Sun Y, Xu J, Xu Q. An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells. Mol. Pharmacol. 76: 1238-1245 (2009).
13. Chen HW, Lee JY, Huang JY, Wang CC, Chen WJ, Su SF, Huang CW, Ho CC, Chen JJ, Tsai MF, Yu SL, Yang PC. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res. 68: 7428-7438 (2008).
14. Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 14: 4491-4499 (2008).
15. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa). J. Altern. Complem. Med. 9: 161-168 (2003).
16. Weng CJ, Yen GC. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: Phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat. Rev. 37: in press (2011).
17. Chen JW, Tang YL, Liu H, Zhu ZY, Lü D, Geng N, Chen Y. Antiproliferative and anti-metastatic effects of curcumin on oral cancer cells. Hua Xi Kou Qiang Yi Xue Za Zhi 29: 83-86 (2011).
18. Mudduluru G, George-William JN, Muppala S, Asangani IA, Kumarswamy R, Nelson LD, Allgayer H. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Bioscience Rep. 31: 185-197 (2011).
19. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products. Cancer Res. 67: 3853-3861 (2007).
20. Bharti AC, Takada Y, Aggarwal BB. Curcumin (diferuloylmethane) inhibits receptor activator of NF-κB ligand-induced NF-κB activation in osteoclast precursors and suppresses osteoclastogenesis. J. Immunol. 172: 5940-5947 (2004).
21. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation. Mol. Pharmacol. 69: 195-206 (2006).
22. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res. 23: 363-398 (2003).
23. SSurh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat. Res. 480-481: 243-268 (2001).
24. Lee KH, Aziz FH, Syahida A, Abas F, Shaari K, Israf DA, Lajis NH. Synthesis and biological evaluation of curcumin-like diarylpentanoid analogues for anti-inflammatory, antioxidant, and anti-tyrosinase activities. Eur. J. Med. Chem. 44: 3195-3200 (2009).
25. Parra M, Lluis F, Miralles F, Caelles C, Munoz-Canoves P. The cJun N-terminal kinase (JNK) signaling pathway mediates induction of urokinase-type plasminogen activator (uPA) by the alkylating agent MNNG. Blood 96: 1415-1424 (2000).
26. Yu YM, Lin HC. Curcumin prevents human aortic smooth muscle cells migration by inhibiting of MMP-9 expression. Nutr. Metab. Cardiovas. 20: 125-132 (2010).
27. Shirley SA, Montpetit AJ, Lockey RF, Mohapatra SS. Curcumin prevents human dendritic cell response to immune stimulants. Biochem. Bioph. Res. Co. 374: 431-436 (2008).
28. Kumar A, Dhawan S, Hardegen NJ, Aggarwal BB. Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-κB activation. Biochem. Pharmacol. 55: 775-783 (1998).
29. Wang CC, Tsai MF, Hong TM, Chang GC, Chen CY, Yang WM, Chen JJ, Yang PC. The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion. Oncogene 24: 4081-4093 (2005).
30. Ogasawara M, Matsunaga T, Suzuki H. Differential effects of antioxidants on the in vitro invasion, growth, and lung metastasis of murine colon cancer cells. Biol. Pharm. Bull. 30: 200-204 (2007).
31. Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT, Lee MT. The antitumor activities of flavonoids. In Vivo 19: 895-909 (2005).
32. Taper HS, Jamison JM, Gilloteaux J, Summers JL, Calderon PB. Inhibition of the development of metastases by dietary vitamin C: K3 combination. Life Sci. 75: 955-967 (2004).
33. Farina HG, Pomies M, Alonso DF, Gomez DE. Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol. Rep. 16: 885-891 (2006).
34. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis, and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 269: 199-225 (2008).
35. Cheng CC, Liu YH, Ho CC, Chao WT, Pei RJ, Hsu YH, Yeh KT, Ho LC, Tsai MC, Lai YS. The influence of plectin deficiency on stability of cytokeratin18 in hepatocellular carcinoma. J. Mol. Histol. 39: 209-216 (2008).
36. Bausch D, Mino-Kenudson M, Fernandez-Del Castillo C, Warshaw AL, Kelly KA, Thayer SP. Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms. J. Gastrointest. Surg. 13: 1948-1954 (2009).
37. Nagata Y, Sonoda T, Mori M, Miyanaga N, Okumura K, Goto K, Naito S, Fujimoto K, Hirao Y, Takahashi A, Tsukamoto T, Akaza H. Dietary isoflavones may protect against prostate cancer in Japanese men. J. Nutr. 137: 1974-1979 (2007).
38. Weinstein SJ, Wright ME, Lawson KA, Snyder K, Männistö S, Taylor PR, Virtamo J, Albanes D. Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Eoidem. Biomar. 16: 1253-1259 (2007).
39. Shiau RJ, Chen KY, Wen YD, Chuang CH, Yeh SL. Genistein and β-carotene enhance the growth-inhibitory effect of trichostatin A in A549 cells. Eur. J. Nutr. 49: 19-25 (2010).
40. Li Y, Upadhyay S, Bhuiyan M, Sarkar FH. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 18: 3166-3172 (1999).
41. Mainiero F, Murgia C, Wary KK, Curatola AM, Pepe A, Blumemberg M, Westwick JK, Der CJ, Giancotti FG. The coupling of [α]6[β]4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO J. 16: 2365-2375 (1997).
42. Wary KK, Mariotti A, Zurzolo C, Giancotti FG. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94: 625-634 (1998).
43. Osmanagic-Myers S, Gregor M, Walko G, Burgstaller G, Reipert S, Wiche G. Plectin-controlled keratin cytoarchitecture affects MAP kinases involved in cellular stress response and migration. J. Cell Biol. 174: 557-568 (2006).
44. Soung YH, Chung J. Curcumin inhibition of the functional interaction between integrin α6β4 and the epidermal growth factor receptor. Mol. Cancer Ther. 10: 883-891 (2011).